Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2005

01-07-2005 | Report

Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer

Authors: Kerstin Wagner, Kari Hemminki, Elisabeth Israelsson, Ewa Grzybowska, Magnus Söderberg, Jolanta Pamula, Wioletta Pekala, Helena Zientek, Danuta Mielzynska, Ewa Siwinska, Asta Försti

Published in: Breast Cancer Research and Treatment | Issue 2/2005

Login to get access
Metadata
Title
Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer
Authors
Kerstin Wagner
Kari Hemminki
Elisabeth Israelsson
Ewa Grzybowska
Magnus Söderberg
Jolanta Pamula
Wioletta Pekala
Helena Zientek
Danuta Mielzynska
Ewa Siwinska
Asta Försti
Publication date
01-07-2005
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/2005
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-2417-x

Other articles of this Issue 2/2005

Breast Cancer Research and Treatment 2/2005 Go to the issue

Report

Transcription factor decoy against promoter C of estrogen receptor α gene induces a functional ERα protein in breast cancer cells

Report

Racial and ethnic disparities in breast cancer rates by age: NAACCR Breast Cancer Project

Report

Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1–5 and correlation with receptor protein expression and tumor pathology

Report

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy

Letter to the editor

On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments

Report

An ecological study of the association of environmental chemicals on breast cancer incidence in Texas
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits